DNA repair enzyme uracil DNA glycosylase is specifically incorporated into human immunodeficiency virus type 1 viral particles through a Vpr-independent mechanism

被引:64
作者
Willetts, KE [1 ]
Rey, F [1 ]
Agostini, I [1 ]
Navarro, JM [1 ]
Baudat, Y [1 ]
Vigne, R [1 ]
Sire, J [1 ]
机构
[1] INSERM, U372, F-13276 Marseille 9, France
关键词
D O I
10.1128/JVI.73.2.1682-1688.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Vpr protein, encoded by the human immunodeficiency virus type 1 (HIV-1) genome, is one of the nonstructural proteins packaged in large amounts into viral particles. We have previously reported that Vpr associates with the DNA repair enzyme uracil DNA glycosylase (UDG). In this study, we extended these observations by investigating whether UDG is incorporated into virions and whether this incorporation requires the presence of Vpr. Our results, with highly purified viruses, show that UDG is efficiently incorporated either into wild-type virions or into Vpr-deficient HIV-1 virions, indicating that Vpr is not involved in UDG packaging. Using an in vitro protein-protein binding assay, we reveal a direct interaction between the precursor form of UDG and the viral integrase (IN). Finally,we demonstrate that IN-defective viruses fail to incorporate UDG, indicating that IN is required for packaging of UDG into virions.
引用
收藏
页码:1682 / 1688
页数:7
相关论文
共 39 条
  • [1] The human immunodeficiency virus type 1 Vpr transactivator: Cooperation with promoter-bound activator domains and binding to TFIIB
    Agostini, I
    Navarro, JM
    Rey, F
    Bouhamdan, M
    Spire, B
    Vigne, R
    Sire, J
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1996, 261 (05) : 599 - 606
  • [2] HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B
    Ayyavoo, V
    Mahboubi, A
    Mahalingam, S
    Ramalingam, R
    Kudchodkar, S
    Williams, WV
    Green, DR
    Weiner, DB
    [J]. NATURE MEDICINE, 1997, 3 (10) : 1117 - 1123
  • [3] Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations
    Bess, JW
    Gorelick, RJ
    Bosche, WJ
    Henderson, LE
    Arthur, LO
    [J]. VIROLOGY, 1997, 230 (01) : 134 - 144
  • [4] Diversity of HIV-1 Vpr interactions involves usage of the WXXF motif of host cell proteins
    BouHamdan, M
    Xue, YN
    Baudat, Y
    Hu, BC
    Sire, J
    Pomerantz, RJ
    Duan, LX
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (14) : 8009 - 8016
  • [5] Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme
    Bouhamdan, M
    Benichou, S
    Rey, F
    Navarro, JM
    Agostini, I
    Spire, B
    Camonis, J
    Slupphaug, G
    Vigne, R
    Benarous, R
    Sire, J
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (02) : 697 - 704
  • [6] Human immunodeficiency virus type 1 Vif protein binds to the Pr55(Gag) precursor
    Bouyac, M
    Courcoul, M
    Bertola, G
    Baudat, Y
    Gabuzda, D
    Blanc, D
    Chazal, N
    Boulanger, P
    Sire, J
    Vigne, R
    Spire, B
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (12) : 9358 - 9365
  • [7] A NUCLEAR-LOCALIZATION SIGNAL WITHIN HIV-1 MATRIX PROTEIN THAT GOVERNS INFECTION OF NONDIVIDING CELLS
    BUKRINSKY, MI
    HAGGERTY, S
    DEMPSEY, MP
    SHAROVA, N
    ADZHUBEI, A
    SPITZ, L
    LEWIS, P
    GOLDFARB, D
    EMERMAN, M
    STEVENSON, M
    [J]. NATURE, 1993, 365 (6447) : 666 - 669
  • [8] COHEN EA, 1990, J ACQ IMMUN DEF SYND, V3, P11
  • [9] The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: Possible implications for the pathogenesis of AIDS
    Conti, L
    Rainaldi, G
    Matarrese, P
    Varano, B
    Rivabene, R
    Columba, S
    Sato, A
    Belardelli, E
    Malorni, W
    Gessani, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (03) : 403 - 413
  • [10] The zinc fingers of HIV nucleocapsid protein NCp7 direct interactions with the viral regulatory protein Vpr
    de Rocquigny, H
    Petitjean, P
    Tanchou, V
    Decimo, D
    Drouot, L
    Delaunay, T
    Darlix, JL
    Roques, BP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) : 30753 - 30759